Merck KGaA header image

Merck KGaA

MRK

Equity

ISIN DE0006599905 / Valor 412799

Xetra (2026-05-06)
EUR 113.97+1.05%

Merck KGaA
UMushroom community rating:

star star star star star
3.00 2 votes No rating yet
NegativeNeutralPositive

About company

Merck KGaA is a global science and technology company headquartered in Darmstadt, Germany, with a history spanning more than 350 years. The company operates across three business sectors: Life Science, Healthcare, and Electronics. In the Life Science sector, Merck provides a wide range of laboratory tools, services, and solutions that support scientific research and bioprocessing for drug manufacturing. The Healthcare division focuses on developing and delivering treatments for serious diseases, including oncology, neurology, immunology, fertility, and endocrinology. Meanwhile, the Electronics sector offers advanced materials, technologies, and solutions for the semiconductor, display, and surface solutions industries. With approximately 63,000 employees in 65 countries, Merck KGaA is dedicated to leveraging science and technology to improve access to health, empower scientific research, and drive human progress through innovation in its diverse fields of operation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-12.1%1Y
-33.2%3Y
-21.7%5Y

Performance

29.2%1Y
27.4%3Y
27.8%5Y

Volatility

Market cap

16816 M

Market cap (USD)

Daily traded volume (Shares)

293,889

Daily traded volume (Shares)

1 day high/low

139.95 / 138.35

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

2 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.50
Tobias Kurz
Switzerland, 30 Mar 2025
star star star star star
-
Theo Clausen
Switzerland, 25 Sep 2024
star star star star star
Currently in a downtrend due to france results, but might surprise us in the future.

EQUITIES OF THE SAME SECTOR

Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.07%USD 301.11
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 297.49
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.84%USD 168.71
Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.35%USD 121.32
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 50.44
Viatris Inc
Viatris Inc Viatris Inc Valor: 58198423
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%USD 15.52
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%USD 56.95
Alignment Healthcare Inc
Alignment Healthcare Inc Alignment Healthcare Inc Valor: 110387702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.98%USD 18.30
Bruker Corp
Bruker Corp Bruker Corp Valor: 1635622
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.45%USD 38.01
Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.21%USD 178.58